Ivan V. Kapustin
Research Subjects
Research Interests
Ivan V. Kapustin has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Irina M. Fedorova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
10 shared publications - Mariya S. Blyakher
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
10 shared publications - Svetlana I. Koteleva
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
10 shared publications - Evgeny E. Odintsov
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
5 shared publications - Svetlana V. Sandalova
G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology
5 shared publications - Elena A. Tulskaya
F. F. Erisman Federal Scientific Center of Hygiene of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
4 shared publications
Latest Publications
- 18 May 2026
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 105 (4)
Influence of the in vitro effect of electromagnetic radiation from a mobile phone on the antigen-specific activity of blood T-lymphocytes in people who have had COVID-19
Introduction. The immune system is one of the objects most sensitive to the effects of the electromagnetic fields. At the same time, the opinion that the effect of radio frequency EMR on cells, tissues, and systems of living organisms is shown at the present stage as distinct and significant is not generally accepted.The aim of the work was to study the effect of EMR on the activity of immune memory T cells against the SARS-CoV-2 virus in vitro when using an irradiation regime corresponding to the usual use of a mobile phone.Materials and methods. The test equipment is a mobile phone with parameters: SAR for the body 1.18 W/kg, for the head 1.25 W/kg, the maximum possible number of functions (bluetooth, WiFi) are connected to the phone.The object of the research was blood samples from forty six people who had suffered from COVID-19 (22 people were ill from November 2020 to July 2021 and 24 were ill from December 2022 to March 2023).Polystyrene plates from the SARS-CoV-2-IgG-ELISA test systems were used for antigenic stimulation (produced by JSC Vector-Best, Russia). To assess the effect of mobile phone EMR, each cell sample (intact or AG-stimulated) was divided into 2 portions. One portion was incubated for 4 hours in the presence of an EMP mobile phone, the second without it. Next, the concentration of interferon-gamma (IFN-γ) in the filler fluid was determined by the ELISA method on test systems from the same company.Results. The effect of EMR has been shown to be expressed in a significant (p < 0.05) decrease in the activity of memory T cells, which, after exposure to EMR, produce IFN-γ weaker during antigen recognition. Only in 4 out of 46 patients, increased activity of memory T cells was detected during antigenic stimulation of lymphocytes in the presence of mobile phone EMR. The average decrease in IFN-γ production was 151.3 ± 80.8 pg/ml or 66.6 ± 11.4% of the baseline level of antigen-stimulated IFN-γ production by patient lymphocytes.Limitations: the use of an in vitro approach.Conclusion. Further investigation of the effect of electromagnetic radiation from a mobile phone on AG-induced lymphocyte activity in people who have suffered from COVID-19 will determine whether the hypersensitivity of AG-specific cells to EMR is associated with impaired immune regulation due to the disease, or EMR can adversly affect AG-specific T cells in healthy people.Compliance with ethical standards. All T-donors gave informed consent to participate in the study, approved by the Ethics Committee of the G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology (Protocol No. 41 dated 12/10/2020).Contribution: Kapustin I.V. – analysis of experimental data, design of illustrations; Tulskaya E.A. – literature data analysis, database maintenance; Blyakher M.S. – research concept and design, editing; Sandalova S.V. – literature data analysis, material collection; Odintsov E.E. – material collection, editing; Koteleva S.I. – cultural research, text writing; Ramazanova Z.K. – collection of material; Fedorova I.M. – statistical processing, text writing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: April 2, 2025 / Revised: November 24, 2025 / Accepted: March 24, 2026 / Published: May 18, 2026
- 18 May 2026
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 105 (4)
Influence of the in vitro effect of electromagnetic radiation from a mobile phone on the antigen-specific activity of blood T-lymphocytes in people who have had COVID-19
Introduction. The immune system is one of the objects most sensitive to the effects of the electromagnetic fields. At the same time, the opinion that the effect of radio frequency EMR on cells, tissues, and systems of living organisms is shown at the present stage as distinct and significant is not generally accepted.The aim of the work was to study the effect of EMR on the activity of immune memory T cells against the SARS-CoV-2 virus in vitro when using an irradiation regime corresponding to the usual use of a mobile phone.Materials and methods. The test equipment is a mobile phone with parameters: SAR for the body 1.18 W/kg, for the head 1.25 W/kg, the maximum possible number of functions (bluetooth, WiFi) are connected to the phone.The object of the research was blood samples from forty six people who had suffered from COVID-19 (22 people were ill from November 2020 to July 2021 and 24 were ill from December 2022 to March 2023).Polystyrene plates from the SARS-CoV-2-IgG-ELISA test systems were used for antigenic stimulation (produced by JSC Vector-Best, Russia). To assess the effect of mobile phone EMR, each cell sample (intact or AG-stimulated) was divided into 2 portions. One portion was incubated for 4 hours in the presence of an EMP mobile phone, the second without it. Next, the concentration of interferon-gamma (IFN-γ) in the filler fluid was determined by the ELISA method on test systems from the same company.Results. The effect of EMR has been shown to be expressed in a significant (p < 0.05) decrease in the activity of memory T cells, which, after exposure to EMR, produce IFN-γ weaker during antigen recognition. Only in 4 out of 46 patients, increased activity of memory T cells was detected during antigenic stimulation of lymphocytes in the presence of mobile phone EMR. The average decrease in IFN-γ production was 151.3 ± 80.8 pg/ml or 66.6 ± 11.4% of the baseline level of antigen-stimulated IFN-γ production by patient lymphocytes.Limitations: the use of an in vitro approach.Conclusion. Further investigation of the effect of electromagnetic radiation from a mobile phone on AG-induced lymphocyte activity in people who have suffered from COVID-19 will determine whether the hypersensitivity of AG-specific cells to EMR is associated with impaired immune regulation due to the disease, or EMR can adversly affect AG-specific T cells in healthy people.Compliance with ethical standards. All T-donors gave informed consent to participate in the study, approved by the Ethics Committee of the G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology (Protocol No. 41 dated 12/10/2020).Contribution: Kapustin I.V. – analysis of experimental data, design of illustrations; Tulskaya E.A. – literature data analysis, database maintenance; Blyakher M.S. – research concept and design, editing; Sandalova S.V. – literature data analysis, material collection; Odintsov E.E. – material collection, editing; Koteleva S.I. – cultural research, text writing; Ramazanova Z.K. – collection of material; Fedorova I.M. – statistical processing, text writing. All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.Conflict of interest. The authors declare no conflict of interest.Funding. The study had no sponsorship.Received: April 2, 2025 / Revised: November 24, 2025 / Accepted: March 24, 2026 / Published: May 18, 2026
- 14 May 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2) , 45-51
Humoral and T-cell immune response against SARS-CoV-2 in children with acute respiratory infections
Objective. The aim was to evaluate specific T-cell and antibodies against SARS-CoV-2 in children hospitalized with respiratory infectious diseases.Materials and methods. Examination of 121 children was carried out in 2021–2024. Among them 22% of patients were under 1 year of age, 33% — 1–3 years, 21% 4–6 years, 24% 7–14 years. In 51 children acute respiratory infection was concomitant with the course of pertussis. Diagnosis of acute respiratory viral infections was based on clinical data and on PCR testing of nasopharyngeal mucus including PCR testing for SARS-CoV-2. Using a method we developed, memory T cells specific to the SARS-CoV-2 S-glycoprotein were assessed in patients' blood. IgG- and IgM-antibodies to SARS-CoV-2 S-glycoprotein in blood serum were also tested.Results. IgG antibodies to S-glycoprotein SARS-CoV-2 were detected in the blood of 55% of children in 2021, 65% in 2022, 82% in 2023, and 96% in 2024. T lymphocytes activated by stimulation with recombinant S-glycoprotein SARS-CoV-2 were detected in the blood of 25% of children in 2021, 70% in 2022 and 19–35% in 2023–2024. A significant (55%) frequency of serologic markers of transmitted undiagnosed COVID-19 was found in children under 3 years of age whose contacts, especially in 2021, were limited to family. In the groups of patients 3–14 years old, even more children were seropositive (95–100%). Memory T cells were found less frequently in children younger 3 years than after 3 years of age.Conclusion. Examination of individuals with various respiratory diseases can clarify ideas about what part of the population has acquired immunity against SARS-CoV-2, as well as assess the role of memory T cells and antibodies to “ancestral” and current strains of SARS-CoV-2 in limiting morbidity.
- 14 May 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2) , 45-51
Humoral and T-cell immune response against SARS-CoV-2 in children with acute respiratory infections
Objective. The aim was to evaluate specific T-cell and antibodies against SARS-CoV-2 in children hospitalized with respiratory infectious diseases.Materials and methods. Examination of 121 children was carried out in 2021–2024. Among them 22% of patients were under 1 year of age, 33% — 1–3 years, 21% 4–6 years, 24% 7–14 years. In 51 children acute respiratory infection was concomitant with the course of pertussis. Diagnosis of acute respiratory viral infections was based on clinical data and on PCR testing of nasopharyngeal mucus including PCR testing for SARS-CoV-2. Using a method we developed, memory T cells specific to the SARS-CoV-2 S-glycoprotein were assessed in patients' blood. IgG- and IgM-antibodies to SARS-CoV-2 S-glycoprotein in blood serum were also tested.Results. IgG antibodies to S-glycoprotein SARS-CoV-2 were detected in the blood of 55% of children in 2021, 65% in 2022, 82% in 2023, and 96% in 2024. T lymphocytes activated by stimulation with recombinant S-glycoprotein SARS-CoV-2 were detected in the blood of 25% of children in 2021, 70% in 2022 and 19–35% in 2023–2024. A significant (55%) frequency of serologic markers of transmitted undiagnosed COVID-19 was found in children under 3 years of age whose contacts, especially in 2021, were limited to family. In the groups of patients 3–14 years old, even more children were seropositive (95–100%). Memory T cells were found less frequently in children younger 3 years than after 3 years of age.Conclusion. Examination of individuals with various respiratory diseases can clarify ideas about what part of the population has acquired immunity against SARS-CoV-2, as well as assess the role of memory T cells and antibodies to “ancestral” and current strains of SARS-CoV-2 in limiting morbidity.
- Open Access
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 205-214
Development and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection
Aim evaluation of specific T-cell immunity against SARS-CoV-2 in primary and secondary response to virus antigens by screening method. Materials and methods. Patients were tested 11.5 months after COVID-19 and 610 months before and after vaccination. Healthy volunteers were screened before, 26 times during the vaccination course, and 68 months after revaccination with the Sputnik V vaccine. IgG and IgM antibodies to SARS-CoV-2 were detected by ELISA using commercially available kits (Vector-Best, Russia). Antigenic (AG) activation of T cells in the fraction of bloods mononuclear cells was assessed by IFN- production after AG stimulation in the wells of plates from ELISA kits intended for detection of antibodies against SARS-CoV-2. Data were processed by MS Excel and Statistica 10.0 software. Results. AG-specific T cells were detected in 88.5% of vaccinated healthy volunteers, half of whom were found to have T cells appearing earlier than antibodies to AG. After 6-8 months, the level of AG activation decreases. Following the revaccination, the level of AG activation of memory T cells in vitro increases within six months in 76.9100.0% of vaccinated subjects. On the contrary, after COVID-19, 86.7% of individuals had in their blood the AG-specific T cells with high activity at the time of vaccination. The activity of T cells recognizing the RBD domain of the SARS-CoV-2 S protein and the proportion of individuals who had these cells in their blood increased after the vaccination of reconvalescents. Conclusion. T-cell immunity against SARS-CoV-2 antigens has been shown to persist for 6 months after illness. In vaccinated individuals without history of COVID-19, such duration of the preservation of AG-specific T cells in blood was only achieved after the revaccination.
- 6 July 2023
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 68 (3) , 205-214
Open AccessDevelopment and preservation of specific T-cell immunity after COVID-19 or vaccination against this infection
Aim evaluation of specific T-cell immunity against SARS-CoV-2 in primary and secondary response to virus antigens by screening method. Materials and methods. Patients were tested 11.5 months after COVID-19 and 610 months before and after vaccination. Healthy volunteers were screened before, 26 times during the vaccination course, and 68 months after revaccination with the Sputnik V vaccine. IgG and IgM antibodies to SARS-CoV-2 were detected by ELISA using commercially available kits (Vector-Best, Russia). Antigenic (AG) activation of T cells in the fraction of bloods mononuclear cells was assessed by IFN- production after AG stimulation in the wells of plates from ELISA kits intended for detection of antibodies against SARS-CoV-2. Data were processed by MS Excel and Statistica 10.0 software. Results. AG-specific T cells were detected in 88.5% of vaccinated healthy volunteers, half of whom were found to have T cells appearing earlier than antibodies to AG. After 6-8 months, the level of AG activation decreases. Following the revaccination, the level of AG activation of memory T cells in vitro increases within six months in 76.9100.0% of vaccinated subjects. On the contrary, after COVID-19, 86.7% of individuals had in their blood the AG-specific T cells with high activity at the time of vaccination. The activity of T cells recognizing the RBD domain of the SARS-CoV-2 S protein and the proportion of individuals who had these cells in their blood increased after the vaccination of reconvalescents. Conclusion. T-cell immunity against SARS-CoV-2 antigens has been shown to persist for 6 months after illness. In vaccinated individuals without history of COVID-19, such duration of the preservation of AG-specific T cells in blood was only achieved after the revaccination.
- Open Access
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 527-537
Assesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents
Introduction. The development of the COVID-19 pandemic has stimulated the scientific research aimed at studying of the mechanisms of formation the immunity against SARS-CoV-2. Currently, there is a need to develop a domestic simple and cost-effective specific method suitable for monitoring of T-cell response against SARS-CoV-2 in reconvalescents and vaccinated individuals. Aim: Development of a screening method for evaluation specific T-cell immunity against SARS-CoV-2. Materials and methods. Total 40 individuals who had mild to moderate COVID-19 and 20 healthy volunteers who did not have a history of this disease were examined. The presence and levels of IgG and IgM antibodies to SARS-CoV-2 were identified in participants sera by ELISA using the diagnostic kits from JSC Vector-Best (Novosibirsk, Russian Federation). Antigenic stimulation of mononuclear cells was carried out on commercial plates with adsorbed whole-virion inactivated SARS-CoV-2 antigen (State Research Center of Virology and Biotechnology VECTOR Novosibirsk, Russian Federation). The concentration of IFN- was measured in ELISA using the test systems from JSC Vector-Best (Novosibirsk, Russian Federation). The immunophenotyping of lymphocytes was performed on a flow cytometer Cytomics FC500 (Beckman Coulter, USA). Statistical data processing was carried out using the Microsoft Excel and STATISTICA 10 software package. Results. Stimulation of mononuclear cells isolated from the peripheral blood with whole-virion inactivated SARS-CoV-2 antigen fixed at the bottom of the wells of a polystyrene plate showed a significantly higher median response in terms of IFN- production in 40 people who had history of COVID-19 compared to 20 healthy blood donors (172.1 [34.3575.1] pg/ml versus 15.4 [6.925.8] pg/ml, p 0.0001). There was no difference in median IFN- levels in supernatants collected from unstimulated mononuclear cells from COVID-19 reconvalescents and healthy donors (2.7 [0.411.4] pg/ml versus 0.8 [0.023.3] pg/ml, p 0.05). The overall sensitivity and specificity of this method were 73% (95% CI 5888%) and 100% (95% CI 100100%), respectively, at a cut-off of 50 pg/ml. Conclusion. The developed method for assessment of the cellular immune response to SARS-CoV-2 can be used as a screening method for monitoring the T-cell response in a population against a new coronavirus infection in recovered people.
- 7 December 2022
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 67 (6) , 527-537
Open AccessAssesment of specific T-cell immunity to SARS-CoV-2 virus antigens in COVID-19 reconvalescents
Introduction. The development of the COVID-19 pandemic has stimulated the scientific research aimed at studying of the mechanisms of formation the immunity against SARS-CoV-2. Currently, there is a need to develop a domestic simple and cost-effective specific method suitable for monitoring of T-cell response against SARS-CoV-2 in reconvalescents and vaccinated individuals. Aim: Development of a screening method for evaluation specific T-cell immunity against SARS-CoV-2. Materials and methods. Total 40 individuals who had mild to moderate COVID-19 and 20 healthy volunteers who did not have a history of this disease were examined. The presence and levels of IgG and IgM antibodies to SARS-CoV-2 were identified in participants sera by ELISA using the diagnostic kits from JSC Vector-Best (Novosibirsk, Russian Federation). Antigenic stimulation of mononuclear cells was carried out on commercial plates with adsorbed whole-virion inactivated SARS-CoV-2 antigen (State Research Center of Virology and Biotechnology VECTOR Novosibirsk, Russian Federation). The concentration of IFN- was measured in ELISA using the test systems from JSC Vector-Best (Novosibirsk, Russian Federation). The immunophenotyping of lymphocytes was performed on a flow cytometer Cytomics FC500 (Beckman Coulter, USA). Statistical data processing was carried out using the Microsoft Excel and STATISTICA 10 software package. Results. Stimulation of mononuclear cells isolated from the peripheral blood with whole-virion inactivated SARS-CoV-2 antigen fixed at the bottom of the wells of a polystyrene plate showed a significantly higher median response in terms of IFN- production in 40 people who had history of COVID-19 compared to 20 healthy blood donors (172.1 [34.3575.1] pg/ml versus 15.4 [6.925.8] pg/ml, p 0.0001). There was no difference in median IFN- levels in supernatants collected from unstimulated mononuclear cells from COVID-19 reconvalescents and healthy donors (2.7 [0.411.4] pg/ml versus 0.8 [0.023.3] pg/ml, p 0.05). The overall sensitivity and specificity of this method were 73% (95% CI 5888%) and 100% (95% CI 100100%), respectively, at a cut-off of 50 pg/ml. Conclusion. The developed method for assessment of the cellular immune response to SARS-CoV-2 can be used as a screening method for monitoring the T-cell response in a population against a new coronavirus infection in recovered people.
- Open Access
- 9 April 2022
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (1) , 132-138-138
Clinical and immunological efficacy of azoximer bromide in pertussis in children
Цель исследования. Клинико-иммунологическая оценка эффективности применения азоксимера бромида у больных коклюшем.Характеристика детей и методы исследования. Под наблюдением находились 50 детей от 6 мес до 14 лет. В комплекс терапии 25 детей (основной группы) был включен азоксимера бромид, 25 больных (группа сравнения) получали базисную терапию.Результаты. Выраженность симптомокомплекса у больных обеих наблюдаемых групп соответствовала течению среднетяжелой формы коклюша. Клинический диагноз был подтвержден методом полимеразной цепной реакции у 60±6,9%, иммуноферментным анализом — у 80±5,7% детей. Как в основной, так и в группе сравнения преобладали пациенты, которые переносили коклюш в ассоциации с острыми респираторными вирусными инфекциями (96,0±3,9 и 92,0±5,4% соответственно). Сочетанное течение коклюша с вирусными инфекциями осложнялось развитием бронхита у 8 (32,0±9,3%), пневмонией — у 7 (28,0±9,0%) детей в основной группе, а в группе сравнения бронхиты наблюдались у 9 (36,0±9,6%), пневмонии — у 5 (20±8,0%) больных. Сопоставление результатов лечения в двух группах детей показало эффективность азоксимера бромида по основным клинико-иммунологическим параметрам. Лечебный эффект определялся прежде всего уменьшением частоты приступов кашля и исчезновением на этом фоне явлений гипоксии. Положительная динамика отмечалась в субпопуляционном составе лимфоцитов, что касалось прежде всего содержания NK-клеток. Интенсивность продукции специфических антител к коклюшному микробу в основной группе также была выше, чем в группе сравнения.Заключение. Применение азоксимера бромида в комплексе терапии больных коклюшем способствует уменьшению и сокращению основных клинических проявлений, а так же улучшению иммунологических параметров.
- 9 April 2022
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 67 (1) , 132-138-138
Open AccessClinical and immunological efficacy of azoximer bromide in pertussis in children
Цель исследования. Клинико-иммунологическая оценка эффективности применения азоксимера бромида у больных коклюшем.Характеристика детей и методы исследования. Под наблюдением находились 50 детей от 6 мес до 14 лет. В комплекс терапии 25 детей (основной группы) был включен азоксимера бромид, 25 больных (группа сравнения) получали базисную терапию.Результаты. Выраженность симптомокомплекса у больных обеих наблюдаемых групп соответствовала течению среднетяжелой формы коклюша. Клинический диагноз был подтвержден методом полимеразной цепной реакции у 60±6,9%, иммуноферментным анализом — у 80±5,7% детей. Как в основной, так и в группе сравнения преобладали пациенты, которые переносили коклюш в ассоциации с острыми респираторными вирусными инфекциями (96,0±3,9 и 92,0±5,4% соответственно). Сочетанное течение коклюша с вирусными инфекциями осложнялось развитием бронхита у 8 (32,0±9,3%), пневмонией — у 7 (28,0±9,0%) детей в основной группе, а в группе сравнения бронхиты наблюдались у 9 (36,0±9,6%), пневмонии — у 5 (20±8,0%) больных. Сопоставление результатов лечения в двух группах детей показало эффективность азоксимера бромида по основным клинико-иммунологическим параметрам. Лечебный эффект определялся прежде всего уменьшением частоты приступов кашля и исчезновением на этом фоне явлений гипоксии. Положительная динамика отмечалась в субпопуляционном составе лимфоцитов, что касалось прежде всего содержания NK-клеток. Интенсивность продукции специфических антител к коклюшному микробу в основной группе также была выше, чем в группе сравнения.Заключение. Применение азоксимера бромида в комплексе терапии больных коклюшем способствует уменьшению и сокращению основных клинических проявлений, а так же улучшению иммунологических параметров.
- Open Access
- 9 December 2021
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 66 (5) , 82-87
Clinical and immunological features of the combined course of pertussis and rhinovirus infection in children
The association of pertussis with various respiratory infections in children is the leading factor determining the complicated course and unfavorable outcome of the disease.Objective. To analyze clinical and immunological features of the combined course of pertussis and rhinovirus infection.Children characteristics and research methods. The authors observed 20 patients: 10 (50%) children were under the age of 1 year, 5 (25%) children of 1–3 years old, 3 (15%) children of 4–6 years, 2 (10%) children of 7 -14 years old.Results. The rhinovirus infection developed mainly at 1-2 weeks of illness in 18 (90%) children. Bronchitis developed in 11 (55%) children, pneumonia – in 4 (20%). Special attention was drawn to the low content of NK cells in 82.4% of patients when assessing the subpopulation composition of lymphocytes. The cytokine profile was characterized by a low level of interferon-gamma and interferon-alpha production – in 94.4 and 61.1% of patients, respectively.Conclusion. The combination of pertussis and rhinovirus infection in children contributes to the uneven course of the disease, the frequent development of bronchopulmonary complications.
- 9 December 2021
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 66 (5) , 82-87
Open AccessClinical and immunological features of the combined course of pertussis and rhinovirus infection in children
The association of pertussis with various respiratory infections in children is the leading factor determining the complicated course and unfavorable outcome of the disease.Objective. To analyze clinical and immunological features of the combined course of pertussis and rhinovirus infection.Children characteristics and research methods. The authors observed 20 patients: 10 (50%) children were under the age of 1 year, 5 (25%) children of 1–3 years old, 3 (15%) children of 4–6 years, 2 (10%) children of 7 -14 years old.Results. The rhinovirus infection developed mainly at 1-2 weeks of illness in 18 (90%) children. Bronchitis developed in 11 (55%) children, pneumonia – in 4 (20%). Special attention was drawn to the low content of NK cells in 82.4% of patients when assessing the subpopulation composition of lymphocytes. The cytokine profile was characterized by a low level of interferon-gamma and interferon-alpha production – in 94.4 and 61.1% of patients, respectively.Conclusion. The combination of pertussis and rhinovirus infection in children contributes to the uneven course of the disease, the frequent development of bronchopulmonary complications.
- Open Access
- 28 June 2021
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 11 (5) , 943-950
Hormone therapy affecting interferon defense in children with infectious mononucleosis
23 children diagnosed with acute infectious mononucleosis were hospitalized and examined after a short prednisolone treatment course. Related interferon status during infection was compared with that in 38 patients with acute infectious mononucleosis receiving no hormone therapy. Interferon status was investigated by Ershov method, allowing to estimate amount of interferon in the blood serum samples or patient blood cell culture by assessing interferon biological activity. Along with measuring IFNα or IFNγ biological activity, their level was quantified by using enzyme immunoassay. Immunological examination conducted on the next day after the end of hormone therapy revealed sharply decreased potential of patient blood cells to produce both IFNα and IFNγ. The multiplicity of IFNα and IFNγ titer reduction in various patients varied by 4–5 and 3–4-fold, respectively. The concentration of IFNα, determined by ELISA, decreased by 4–6-fold, whereas for IFNγ — by 1.5–2-fold. A follow-up examination 1 month after discharge from the clinic showed that mean IFNα titer in children aged 3–6 years and treated with prednisolone was significantly reduced compared to the baseline, whereas most patients receiving no hormone therapy had normal IFNα production. The change in the level of IFNα 1 month after hormone therapy in 7–14-year age group was similar. IFNγ production quickly recovered, and 1 month after discharge from the clinic, its concentration in culture supernatants from patients reached 10–15 ng/ml, exceeding normal values more than twice. The biological activity of IFNγ in these culture supernatants was significantly higher than those immediately after hormone therapy, whereas in 3–6-year-old group of patients it was also higher than baseline level. These results can serve as a laboratory justification for including recombinant IFNα-2b drugs in the therapy of such patients, presumably immediately after the end of hormone course. Overall, laboratory justified administration of interferon preparations seems to be necessary to determine optimal timepoint for applying such drugs to increase effectiveness for achieving a durable patient recovery.
- 28 June 2021
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 11 (5) , 943-950
Open AccessHormone therapy affecting interferon defense in children with infectious mononucleosis
23 children diagnosed with acute infectious mononucleosis were hospitalized and examined after a short prednisolone treatment course. Related interferon status during infection was compared with that in 38 patients with acute infectious mononucleosis receiving no hormone therapy. Interferon status was investigated by Ershov method, allowing to estimate amount of interferon in the blood serum samples or patient blood cell culture by assessing interferon biological activity. Along with measuring IFNα or IFNγ biological activity, their level was quantified by using enzyme immunoassay. Immunological examination conducted on the next day after the end of hormone therapy revealed sharply decreased potential of patient blood cells to produce both IFNα and IFNγ. The multiplicity of IFNα and IFNγ titer reduction in various patients varied by 4–5 and 3–4-fold, respectively. The concentration of IFNα, determined by ELISA, decreased by 4–6-fold, whereas for IFNγ — by 1.5–2-fold. A follow-up examination 1 month after discharge from the clinic showed that mean IFNα titer in children aged 3–6 years and treated with prednisolone was significantly reduced compared to the baseline, whereas most patients receiving no hormone therapy had normal IFNα production. The change in the level of IFNα 1 month after hormone therapy in 7–14-year age group was similar. IFNγ production quickly recovered, and 1 month after discharge from the clinic, its concentration in culture supernatants from patients reached 10–15 ng/ml, exceeding normal values more than twice. The biological activity of IFNγ in these culture supernatants was significantly higher than those immediately after hormone therapy, whereas in 3–6-year-old group of patients it was also higher than baseline level. These results can serve as a laboratory justification for including recombinant IFNα-2b drugs in the therapy of such patients, presumably immediately after the end of hormone course. Overall, laboratory justified administration of interferon preparations seems to be necessary to determine optimal timepoint for applying such drugs to increase effectiveness for achieving a durable patient recovery.
- Open Access
- 1 March 2021
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 23 (1) , 179-184
Phage therapy in antibiotic resistant pneumonia: immunomodulation or redistribution?
Our report concerns the observations made during the treatment of pneumonia with individually selected bacteriophages in HCAI patients on mechanical ventilation. 19 patients on mechanical ventilation whose condition was complicated by antibiotic-resistant pneumonia were examined. The treatment of patients was supplemented with phage therapy, bacteriophages were selected individually for each patient, taking into account the microbial etiology of the disease (Pseudomonas aeruginosa, Кlebsiella pneumoniae, Acinetobacter baumanii). Immunophenotyping of blood lymphocytes was carried out using 2-3-parameter flow cytometry. The functional activity of blood leukocytes was assessed by their ability to produce IFNα and IFNγ during cultivation. The level of interferons production in supernatants collected after cultivation was quantitatively evaluated both by their concentration (ELISA, reagents from “Vector-Best-Europe”, Russia) and by their biological activity. Statistical processing of the results was carried out using the Statistica 6 program according to the nonparametric Mann-Whitney U-test. In the course of successful phage therapy with individually selected bacteriophages overcoming of lymphopenia (if there was one) and an increase in both the number and functional activity of peripheral blood lymphocytes in all patients with pneumonia observed are noted. The relationship between the microbial load (mono- or mixed infection, the number of CFU pathogens of pneumonia, the need for repeated courses of phage therapy) and the degree of deficiency in one or another subpopulation of lymphocytes was not detected. Activation of the immune system achieved after one course of phage therapy was maintained for at least 3 weeks after phage administration was discontinued.
- 1 March 2021
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 23 (1) , 179-184
Open AccessPhage therapy in antibiotic resistant pneumonia: immunomodulation or redistribution?
Our report concerns the observations made during the treatment of pneumonia with individually selected bacteriophages in HCAI patients on mechanical ventilation. 19 patients on mechanical ventilation whose condition was complicated by antibiotic-resistant pneumonia were examined. The treatment of patients was supplemented with phage therapy, bacteriophages were selected individually for each patient, taking into account the microbial etiology of the disease (Pseudomonas aeruginosa, Кlebsiella pneumoniae, Acinetobacter baumanii). Immunophenotyping of blood lymphocytes was carried out using 2-3-parameter flow cytometry. The functional activity of blood leukocytes was assessed by their ability to produce IFNα and IFNγ during cultivation. The level of interferons production in supernatants collected after cultivation was quantitatively evaluated both by their concentration (ELISA, reagents from “Vector-Best-Europe”, Russia) and by their biological activity. Statistical processing of the results was carried out using the Statistica 6 program according to the nonparametric Mann-Whitney U-test. In the course of successful phage therapy with individually selected bacteriophages overcoming of lymphopenia (if there was one) and an increase in both the number and functional activity of peripheral blood lymphocytes in all patients with pneumonia observed are noted. The relationship between the microbial load (mono- or mixed infection, the number of CFU pathogens of pneumonia, the need for repeated courses of phage therapy) and the degree of deficiency in one or another subpopulation of lymphocytes was not detected. Activation of the immune system achieved after one course of phage therapy was maintained for at least 3 weeks after phage administration was discontinued.
- Open Access
- 20 October 2020
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 99 (9) , 925-929-929
Impact of a cellphone electromagnetic radiation on phagocytic activity of neutrophils in vitro
Introduction. The nature of a cellphone electromagnetic radiation (EMP) influence on the neutrophils in vitro activation was studied. The relevance of studying the impact of mobile communications and their effects on the body’s physiological processes is determined by the global prevalence of such tools and the research data inconsistency in the both domestic and foreign scientific literature. Material and methods. The object of the study was the whole venous blood samples and isolated neutrophils from 36 adult donors (aged from 22 to 65 years) of both genders. The responses of the neutrophils’ phagocytic activity and its registration were carried out in a flat-bottomed plate for enzyme-linked immunosorbent assay (ELISA), the daily culture of S. aureus ATCC 6538 (strain 209) was used as an inducer of phagocytosis. The intensity of phagocytosis was evaluated by changing the activity of myeloperoxidase (MPO) spectrophotometric method in our modification. Results. In the course of studies of the EMR impact of a cellphone on phagocytic neutrophils, the following was revealed: when culturing neutrophils without the addition of S. aureus, there was a tendency to increase spontaneous MPO activity (by 69%), i.e. its production in the absence of a stimulating factor and, conversely, a significant decrease in the enzyme activity induced by S. aureus (by 34%, p <0.05), i.e. the phagocytic activity of neutrophils. Conclusion We revealed the biological effect of the cellphone EMR as an increase in the spontaneous activity of MPO and a decrease in the bacterially induced activity of the enzyme may indicate a decline in the phagocytic activity of the main cells of the immune system, therefore, it demonstrates a weakening of the protective properties of the human body against infectious diseases. In previous studies, we have shown the presence of the impact of cellphone EMR on the activation of lymphocytes in vitro. The use of immunological tests can be a promising direction in assessing the impact of the cellphone EMR on the human body.
- 20 October 2020
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 99 (9) , 925-929-929
Open AccessImpact of a cellphone electromagnetic radiation on phagocytic activity of neutrophils in vitro
Introduction. The nature of a cellphone electromagnetic radiation (EMP) influence on the neutrophils in vitro activation was studied. The relevance of studying the impact of mobile communications and their effects on the body’s physiological processes is determined by the global prevalence of such tools and the research data inconsistency in the both domestic and foreign scientific literature. Material and methods. The object of the study was the whole venous blood samples and isolated neutrophils from 36 adult donors (aged from 22 to 65 years) of both genders. The responses of the neutrophils’ phagocytic activity and its registration were carried out in a flat-bottomed plate for enzyme-linked immunosorbent assay (ELISA), the daily culture of S. aureus ATCC 6538 (strain 209) was used as an inducer of phagocytosis. The intensity of phagocytosis was evaluated by changing the activity of myeloperoxidase (MPO) spectrophotometric method in our modification. Results. In the course of studies of the EMR impact of a cellphone on phagocytic neutrophils, the following was revealed: when culturing neutrophils without the addition of S. aureus, there was a tendency to increase spontaneous MPO activity (by 69%), i.e. its production in the absence of a stimulating factor and, conversely, a significant decrease in the enzyme activity induced by S. aureus (by 34%, p <0.05), i.e. the phagocytic activity of neutrophils. Conclusion We revealed the biological effect of the cellphone EMR as an increase in the spontaneous activity of MPO and a decrease in the bacterially induced activity of the enzyme may indicate a decline in the phagocytic activity of the main cells of the immune system, therefore, it demonstrates a weakening of the protective properties of the human body against infectious diseases. In previous studies, we have shown the presence of the impact of cellphone EMR on the activation of lymphocytes in vitro. The use of immunological tests can be a promising direction in assessing the impact of the cellphone EMR on the human body.